Zolpidem: a review of its use in the management of insomnia.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  CNS Drugs

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00023210-200519010-00008PMID 15651908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.

  2004cited by this paper
• Effects of daytime administration of zolpidem versus triazolam on memory

  2004cited by this paper
• Clinical and socioeconomic correlates of insomnia.

  2004cited by this paper
• Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.

  2004cited by this paper
• Residual Effects of Hypnotics

  2004cited by this paper
• Comparative Pharmacokinetics and Pharmacodynamics of Short-Acting Hypnosedatives

  2004cited by this paper
• Residual effects of sleep medication on driving ability.

  2004cited by this paper
• ‘As-Needed’ Prescription of Zolpidem for Insomnia in Routine General Practice

  2004cited by this paper
• Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.

  2004cited by this paper
• The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium.

  2004cited by this paper
• A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials.

  2003cited by this paper
• New Drugs for Insomnia

  2003cited by this paper
• Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.

  2003cited by this paper
• Consensus on Drug Treatment, Definition and Diagnosis for Insomnia

  2003cited by this paper
• Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men.

  2003cited by this paper
• Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon

  2003cited by this paper
• Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg

  2003cited by this paper
• Measuring outcomes in randomized clinical trials of insomnia treatments.

  2003cited by this paper
• Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo

  2003cited by this paper
• “As Needed” Pharmacotherapy Combined with Stimulus Control Treatment in Chronic Insomnia—Assessment of a Novel Intervention Strategy in a Primary Care Setting

  2002cited by this paper
• Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study

  2002cited by this paper
• Residual Effects of Middle-of-the-Night Administration of Zaleplon and Zolpidem on Driving Ability, Memory Functions, and Psychomotor Performance

  2002cited by this paper
• Zolpidem Pharmacokinetic Properties in Young Females: Influence of Smoking and Oral Contraceptive Use

  2002cited by this paper
• CONSENSUS FOR THE PHARMACOLOGICAL MANAGEMENT OF INSOMNIA IN THE NEW MILLENNIUM

  2001cited by this paper
• Efficacy and Safety of Zolpidem Administered ‘As Needed’ in Primary Insomnia

  2001cited by this paper
• Insomnia: therapeutic approach.

  2001cited by this paper
• El efecto del zolpidem en los pacientes con insomnio de corta evolución

  2001cited by this paper
• A Double-Blind Comparative Study of Zolpidem versus Zopiclone in the Treatment of Chronic Primary Insomnia

  2001cited by this paper
• Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening

  2001cited by this paper
• Hypnotic dependence: zolpidem and zopiclone too.

  2001cited by this paper
• Benzodiazepines and hip fractures in elderly people: case-control study

  2001cited by this paper
• Comparative efficacy of zolpidem and temazepam in transient insomnia

  2001cited by this paper
• A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.

  2001cited by this paper
• Zolpidem Use and Hip Fractures in Older People

  2001cited by this paper
• Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer.

  2000cited by this paper
• Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.

  2000cited by this paper
• Comparison of the effects of zolpidem and zopiclone on nocturnal sleep and sleep latency in the morning: a cross-over study in healthy young volunteers.

  2000cited by this paper
• Comparison of the effects of zolpidem and zopiclone on nocturnal sleep and sleep latency in the morning: A cross-over study in healthy young volunteers

  2000cited by this paper
• Eight weeks of non-nightly use of zolpidem for primary insomnia.

  2000cited by this paper
• Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

  2000cited by this paper
• The effect of zolpidem and zopiclone on memory.

  2000cited by this paper
• Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.

  2000cited by this paper
• Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.

  2000cited by this paper
• Zaleplon improves sleep without producing rebound effects in outpatients with insomnia

  2000cited by this paper
• Residual effects of hypnotics on disengagement of spatial attention

  2000cited by this paper
• The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance.

  2000cited by this paper
• Central nervous system side effects associated with zolpidem treatment.

  2000cited by this paper
• [Safety profile of zolpidem: two studies of 3805 patients by Swiss practitioners].

  1999cited by this paper
• Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.

  1999cited by this paper
• Zolpidem for persistent insomnia in SSRI-treated depressed patients.

  1999cited by this paper
• Residual effects of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades

  1999cited by this paper
• Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.

  1999cited by this paper
• Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects.

  1999cited by this paper
• Withdrawal Reactions after Stopping Hypnotics in Patients with Insomnia

  1998cited by this paper
• Comparison of the Effects of Zolpidem and Flunitrazepam on Sleep Structure and Daytime Cognitive Functions - A Study of Untreated Unsomniacs

  1998cited by this paper
• Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo

  1998cited by this paper
• Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII–R primary insomnia

  1998cited by this paper
• Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post‐marketing surveillance of 16 944 cases

  1998cited by this paper
• Comparison of Continuous versus Intermittent Administration of Zolpidem in Chronic Insomniacs: A Double-Blind, Randomized Pilot Study

  1998cited by this paper
• Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers

  1997cited by this paper
• Minimal rebound insomnia after treatment with 10-mg zolpidem.

  1997cited by this paper
• Subjective Efficacy of Zolpidem in Outpatients with Chronic Insomnia

  1997cited by this paper
• Double‐blind, placebo‐controlled comparison of zolpidem, triazolam, and temazepam in elderly patients with insomnia

  1997cited by this paper
• Rebound insomnia after abrupt discontinuation of hypnotic treatment: double‐blind randomized comparison of zolpidem versus triazolam

  1996cited by this paper
• Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.

  1996cited by this paper
• Effects of daytime administration of zolpidem and triazolam on performance.

  1996cited by this paper
• Sleep in patients with chronic primary insomnia during long‐term zolpidem administration and after its withdrawal

  1996cited by this paper
• Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial.

  1996cited by this paper
• Amnesia Possibly Associated with Zolpidem Administration

  1996cited by this paper
• Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics

  1995cited by this paper
• Gradual withdrawal of zopiclone (7.5 mg) and zolpidem (10 mg) in insomniacs treated for at least 3 months

  1995cited by this paper
• Antagonizing the effects of experimentally induced sleep disturbance in healthy volunteers by lormetazepam and zolpidem.

  1995cited by this paper
• Comparison of the Residual Effects and Efficacy of Short Term Zolpidem, Flurazepam and Placebo in Patients with Chronic Insomnia

  1995cited by this paper
• Zolpidem in Insomnia: A 3-Year Post-Marketing Surveillance Study in Switzerland

  1995cited by this paper
• Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers.

  1994cited by this paper
• Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.

  1994cited by this paper
• Randomized, double blind trial of zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice.

  1994cited by this paper
• A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.

  1994cited by this paper
• Safety of long-term zolpidem treatment in patients with insomnia

  1994cited by this paper
• Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.

  1993cited by this paper
• Comparison of the Effects of Zolpidem and Triazolam on Memory Functions, Psychomotor Performances, and Postural Sway in Healthy Subjects

  1993cited by this paper
• Evaluation of zolpidem on alertness and psychomotor abilities among aviation ground personnel and pilots.

  1993cited by this paper
• The Safety and Efficacy of Zolpidem in Insomniac Patients: A Long-Term Open Study in General Practice

  1992cited by this paper
• Long-Term Treatment of Insomnia with Zolpidem: A Multicentre General Practitioner Study of 107 Patients

  1991cited by this paper
• Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential.

  1990cited by this paper

• Quinoline-imidazo[1,2-a]pyridine conjugates as potential antioxidant agents: synthesis, experimental and theoretical approaches

  2026cites this paper
• DFT studies of 2-oxo-2-phenylethyl 3-nitroso-2-phenylimidazo[1,2-a]pyridine-8-carboxylate compound

  2025cites this paper
• Visible Light‐Mediated Preparation of a Key Intermediate Employed in the Synthesis of Zolpidem and Several Analogs

  2025cites this paper
• Recent advances in magnetic nanocatalysts for synthesis of imidazo[1,2-a]pyridine frameworks

  2025cites this paper
• Dependence on zopiclone: a case report

  2025cites this paper
• Zn(II)-Stabilized Radical Ligand Enabled Radical-Type C(sp3)-H Activation-Cascade Cyclization to Imidazopyridines.

  2025cites this paper
• Magnetic nanocatalyst for microwave-assisted synthesis of Benzo[4,5]imidazo[1,2-a]pyrimidines via A3 coupling

  2025cites this paper
• K2S2O8‐Promoted Direct Chalcogenation and Nitrosation at C‐3 Position of Imidazo[1,2‐a]pyridines Under Mild Conditions

  2025cites this paper
• Copper Promoted 8-Aminoimidazo[1,2-a]pyridine-Directed Additive-Free Ortho C(sp 2 )–H C–S, C–Se Functionalization of (Hetero)Arenes

  2025cites this paper
• Advances in Z-drug detection.

  2025cites this paper
• ZnFe2O4-SiO2@PC-Ni nanoparticles for one-pot, solvent-free synthesis of imidazo[1,2-a]pyridines by A3 coupling reactions under ultrasound conditions

  2025cites this paper
• Medical management for cerebellar mutism syndrome following posterior fossa surgery: A systematic review.

  2024cites this paper
• Imidazo[1,2-a]pyridine and Imidazo[1,5-a]pyridine: Electron Donor Groups in the Design of D-π-A Dyes.

  2024cites this paper
• Synthesis of 6- or 8-Carboxamido Derivatives of Imidazo[1,2-a]pyridines via a Heterogeneous Catalytic Aminocarbonylation Reaction

  2024cites this paper
• Progress in GABAA receptor agonists for insomnia disorder

  2024cites this paper
• Evaluation of the protective effect of vitamin E on sperm parameters in the mice exposed to zolpidem

  2024cites this paper
• Zolpidem-related euphoria, addiction and detoxification: A case report and review of the literature

  2024cites this paper
• Various Synthesis of Imidazo[1,2-a]pyridines Derivatives and Therapeutic Significance: A Review

  2024cites this paper
• Design and synthesis of imidazo[1,2‐a]pyridine‐chalcone conjugates as antikinetoplastid agents

  2023cites this paper
• Annulation of α-bromocinnamaldehydes to access 3-formyl-imidazo[1,2-α]pyridines and pyrimidines under transition metal-free conditions.

  2023cites this paper
• Synthesis, characterization, crystal structure, Hirshfeld analysis and theoretical investigation of 5-(4-methoxyphenyl)-7-phenyl-2-(pyridin-2-yl)imidazo[1,2-a]pyridine-8-carbonitrile

  2023cites this paper
• The top 100 most cited papers in insomnia: A bibliometric analysis

  2023cites this paper
• Synthesis and Biological Evaluation of Tetrazole fused Imidazopyridine Derivatives as Anticancer Agents

  2023cites this paper
• Design, synthesis and biological studies of tetrazole fused imidazopyridines

  2023cites this paper
• Speedy Gonzales analysis method in one drop of beverage, for crimes committed with drugs from three different groups

  2023cites this paper
• Silica-Zinc Chloride (SiO_2-ZnCl_2)-Mediated Facile Synthesis of Some Nitro-Substituted Arylimidazopyridine Analogs

  2023cites this paper
• KI-Oxone catalyzed ultrasound-promoted synthesis of imidazo[1,2-a]-pyridine-3-carboxylates (IPCs) and evaluation of their anti-tubercular activity

  2023cites this paper
• Arousal Regulation by the External Globus Pallidus: A New Node for the Mesocircuit Hypothesis

  2023cites this paper
• A Facile Access to the Synthesis of Highly Functionalized Novel 4H-pyrano[2',3':4,5]imidazo[1,2-a]pyridine hybrid via One-pot Four-Component Domino Reaction

  2023cites this paper
• Synthesis of Imidazo[1,2-a]pyridine-Fused 1,3-Benzodiazepine Derivatives with Anticancer Activity via a One-Pot Cascade GBB-3CR/Pd(II)-Catalyzed Azide-Isocyanide Coupling/Cyclization Process.

  2023cites this paper
• Synthesis and Biological Evaluation of Novel Amide Derivatives of 1,2,4-Oxadiazole-Imidazopyridines as Anticancer Agents

  2023cites this paper
• Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials

  2022cites this paper
• Synthesis of 3-N-/O-/S-methyl-imidazo[1,2-a] pyridine derivatives for caspase-3 mediated apoptosis induced anticancer activity.

  2022cites this paper
• Iodine promoted synthesis of pyrido[2′,1′:2,3]imidazo[4,5-c]quinoline derivatives via oxidative decarboxylation of phenylacetic acid

  2022cites this paper
• Synthesis of Tunable Fluorescent Imidazole-Fused Heterocycle Dimers

  2022cites this paper
• Crystal structure and Hirshfeld surface analysis of 2-oxo-2-phenylethyl 3-nitroso-2-phenylimidazo[1,2-a]pyridine-8-carboxylate

  2022cites this paper
• Visible‐Light‐Promoted Synthesis of Fusesd Imidazoheterocycle by Eosin Y under Metal‐Free and Solvent‐Free Conditions

  2021cites this paper
• One-Pot Synthesis of 3-Methyl-2-arylimidazo[1,2-a]pyridines Using Calcium Carbide as an Alkyne Source.

  2021cites this paper
• Electrochemical sulfonylation of imidazoheterocycles under batch and continuous flow conditions.

  2021cites this paper
• Sleep in Space Environment

  2021cites this paper
• Synthesis, crystal structure and vibrational properties of N-(8-(3-(3-(tert-butyl)ureido)phenyl)imidazo[1,2-a]pyridin-6-yl)acetamide

  2021cites this paper
• Pyridine Derivatives as Biologically Active Precursors; Organics and Selected Coordination Complexes

  2021cites this paper
• Sulfur Catalyzed Metal‐ and Solvent‐Free ABB'C Four‐Component Synthesis of N ‐Arylidene‐2‐aryl‐imidazo[1‐2‐ a ]azin‐3‐amines via Strecker Reaction

  2021cites this paper
• Annulation of Conjugated Azine-Imine with a Sulfoxonium Ylide in a Noncarbenoid Route to Synthesize Multisubstituted Imidazole-Fused Heterocycles.

  2021cites this paper
• Determination of zolpidem phenyl-4-carboxylic acid and zolpidem 6-carboxylic acid in hair using gas chromatography-electron ionization-tandem mass spectrometry.

  2021cites this paper
• An electrolyte- and catalyst-free electrooxidative sulfonylation of imidazo[1,2-a]pyridines

  2021cites this paper
• 8-Aminoimidazo[1,2-a]pyridine (AIP) directed Pd(II) catalysis: site-selective ortho-C(sp2)-H arylation in aqueous medium.

  2021cites this paper
• ‘Z-trip’? A Comprehensive Overview and a Case-series of Zolpidem Misuse

  2021influential citation
• Selective extraction of zolpidem from plasma using molecularly imprinted polymer followed by high performance liquid chromatography

  2021cites this paper
• Copper(I/II)-Promoted Diverse Imidazo[1,2-α]pyridine Synthesis on Solid-Phase Bound DNA Oligonucleotides for Encoded Library Design.

  2021cites this paper
• Recent Advances in the Use of the Dimerization Strategy as a Means to Increase the Biological Potential of Natural or Synthetic Molecules

  2021cites this paper
• KIO4-mediated selective hydroxymethylation /methylenation of imidazo-heteroarenes: a greener approach.

  2021cites this paper
• Multicomponent one pot synthesis of C-glucosides of 1-azaindolizines

  2020cites this paper
• Principles of Neurochemistry: Fundamentals and Applications

  2020cites this paper
• Sustainable Synthetic Approaches for 3‐Aminoimidazo‐fused HeterocyclesviaGroebke‐Blackburn‐Bienaymé Process

  2020cites this paper
• A Practical and Versatile Method for the C–H Sulfenylation of Imidazo[1,2-a]pyridines

  2020cites this paper
• Palladium-catalyzed C3-selective C–H oxidative carbonylation of imidazo[1,2-a]pyridines with CO and alcohols: a way to access esters

  2020cites this paper
• CuCl2-catalyzed N O bond cleavage of oxime esters: Approach to imidazoheterocycles and furo[3,2-c]chromenyl fused imidazoles

  2020cites this paper
• TEMPO-mediated cross dehydrogenative coupling aminomethylation of imidazopyridine

  2020cites this paper
• Design, synthesis, and biological evaluation of chalcone-linked thiazole-imidazopyridine derivatives as anticancer agents

  2020cites this paper
• High-dose zolpidem abuse in a patient with insomnia comorbid with major depressive disorder

  2020cites this paper
• Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects

  2020cites this paper
• Electro-organic synthesis of tetrahydroimidazo[1,2-a]pyridin-5(1H)-one via a multicomponent reaction

  2020cites this paper
• Benzimidazole Containing Acetamide Derivatives Attenuate Neuroinflammation and Oxidative Stress in Ethanol-Induced Neurodegeneration

  2020cites this paper
• Hypnotika und Sedativa

  2020cites this paper
• Magnetically separable nanocatalyzed synthesis of bioactive heterocycles in water

  2020cites this paper
• Comparative bioavailability of two zolpidem hemitartrate formulations in healthy human Brazilian volunteers using high-performance liquid chromatography coupled to tandem mass spectrometry.

  2020cites this paper
• Chemistry of Neurochemicals: Psychopharmaceuticals and Neuropeptides

  2020cites this paper
• CuI/Fe 3 O 4 NPs@Biimidazole IL‐KCC‐1 as a leach proof nanocatalyst for the synthesis of imidazo[1,2‐ a ]pyridines in aqueous medium

  2020cites this paper
• Advancements in chemical methodologies for the synthesis of 3-aroylimidazo[1,2-a]pyridines: an update of the decade

  2020cites this paper
• Synthesis, Characterization, and Antiproliferative Activity Studies of Novel Benzimidazole‐Imidazopyridine Hybrids as DNA Groove Binders

  2020cites this paper
• High-dose zolpidem abuse in a patient with insomnia comorbid with major depressive disorder

  2020cites this paper
• Visible-Light-Induced Dehydrogenative Imidoylation of Imidazo[1,2-a]pyridines with α-Amino Acid Derivatives and α-Amino Ketones.

  2020cites this paper
• Palladium catalyzed 8-aminoimidazo[1,2-a]pyridine (AIP) directed selective β-C(sp2)-H arylation.

  2020cites this paper
• Sonication assisted One-Pot Synthesis of Substituted Imidazopyridine from Styrene in Water.

  2020cites this paper
• Temporal association between zolpidem medication and the risk of suicide: A 12-year population-based, retrospective cohort study

  2020cites this paper
• Preparation of some novel imidazopyridine derivatives of indole as anticancer agents: one-pot multicomponent synthesis, biological evaluation and docking studies

  2019cites this paper
• Copper‐Catalyzed Domino Synthesis of Sulfur‐Containing Heterocycles Using Carbon Disulfide as a Building Block

  2019cites this paper
• Metal-Free Approach to Zolpidem, Alpidem and their Analogues via Amination of Dibromoalkenes Derived from Imidazopyridine and Imidazothiazole

  2019cites this paper
• Iodine mediated oxidative cross coupling of 2-aminopyridine and aromatic terminal alkyne: a practical route to imidazo[1,2-a]pyridine derivatives.

  2019cites this paper
• A case of zolpidem dependence with extremely high daily doses

  2019cites this paper
• Metal‐Free Regioselective Carbonylation of Imidazo[1,2‐ a ]pyridines via Photoredox Catalysis using Nitrones

  2019cites this paper
• Pharmacodynamic and pharmacokinetic profile of SM‐1, a triple‐drug combination to increase total sleep time

  2019cites this paper
• TFA-catalysed tandem double cyclisation: A one-pot, metal-free routes for novel indolo-imidazo[1,2-a]pyridine derivatives

  2019cites this paper
• Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews

  2019cites this paper
• Photocatalyst-free decarboxylative aminoalkylation of imidazo[1,2-a]pyridines with N-aryl glycines enabled by visible light

  2019cites this paper
• Comparative single-dose bioavailability study of two 10 mg Zolpidem tablet formulations in healthy volunteers

  2019cites this paper
• Exploration of imidazole and imidazopyridine dimers as anticancer agents: Design, synthesis, and structure–activity relationship study

  2019cites this paper
• Transition-metal-free, visible-light-mediated regioselective C–H trifluoromethylation of imidazo[1,2-a]pyridines

  2019cites this paper
• Heterogeneous Copper-Catalyzed Cascade Three-Component Reaction Towards Imidazo[1,2-a]pyridines: Efficient and Practical One-Pot Synthesis of Alpidem

  2019cites this paper
• Crystal Correlation Of Heterocyclic Imidazo[1,2-a]pyridine Analogues and Their Anticholinesterase Potential Evaluation

  2019cites this paper
• Cross-Dehydrogenative Coupling in the Synthesis and Functionalization of Fused Imidazoheterocycles

  2019cites this paper
• Synthesis of 5-Aryl-5H-pyrido[2',1':2,3]imidazo[4,5-b]indoles by Domino Pd- and Cu-Catalyzed C–N Coupling Reactions

  2019cites this paper
• Visible-light-promoted sulfonylmethylation of imidazopyridines

  2019cites this paper
• Electrochemical Synthesis of 3‐Bromoimidazo[1,2‐a]pyridines Directly from 2‐Aminopyridines and alpha ‐Bromoketones

  2019cites this paper
• Copper-Catalysed Multicomponent Syntheses of Heterocycles

  2019cites this paper
• Zolpidem and Gender: Are Women Really At Risk?

  2019cites this paper
• Nano-silica supported palladium nanoparticles: A sustainable nanocatalyst for efficient synthesis of 2,3-diarylimidazo[1,2-a]pyridines at low catalyst loading

  2018cites this paper
• Zolpidem-induced sneezing

  2018cites this paper
• Copper oxide nanoparticle catalysed synthesis of imidazo[1,2-a]pyrimidine derivatives, their optical properties and selective fluorescent sensor towards zinc ion

  2018cites this paper